<DOC>
	<DOCNO>NCT00554281</DOCNO>
	<brief_summary>Hypoglycemia common complication Type 1 diabetes particularly strive good glycemic control . In patient loss awareness hypoglycaemia first manifestation hypoglycaemia may confusion coma . Such situation may carry risk patient may harm self . Medtronic recently develop continuous glucose sensor determines glucose level every 3 minute use subcutaneous sensor transmits information remote device ( Paradigm RT ) may wear leave close eg bedside table . The device may program alarm rapidly fall glucose low glucose level . We propose use 16 patient severe hypoglycemia evidence high HYPO score see decrease number hypoglycemic reaction document improvement well HYPO score .</brief_summary>
	<brief_title>Using Glucose Sensors Prevent Hypoglycemia</brief_title>
	<detailed_description>Sixteen patient Type 1 diabetes ( define : onset age 25 , lean time onset , continuous insulin use , and/or history ketoacidosis C-peptide negative ) , HYPO score seventy-fifth percentile ( &gt; 423 ) , approach offer study . The study conduct three month time-frame . The first month run-in period participant collect four week glucose reading information hypoglycemic event . These record use calculate baseline modify HYPO score . Patients screen first month thyroid disease , celiac disease Addison 's disease . During second month meet study nurse intensive instruction period use Paradigm RT sensor . They spend month practicing use sensor confirm use adequately . During final month wear sensor collect glucose hypoglycemia record calculation final modify HYPO score . The end point change baseline modify HYPO score final four week HYPO score would use identify improvement .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<criteria>Type 1 Diabetes Mellitus confirm Cpeptide &lt; 0.10 nmol/L age 18 70 yr . HYPO score &gt; 423 normal TSH , serum cortisol antitransglutaminase ( ATTG ) current diagnosis cancer planning pregnancy Inability give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Type 1 diabetes</keyword>
	<keyword>Hypoglycemia</keyword>
	<keyword>Glucose sensor</keyword>
</DOC>